Volume 3 Number 5

Website Exclusive Contents!
Exclusive contents: images and/or videos
• Treatment of a giant aortocoronary saphenous vein bypass graft aneurysm
Ohlow MA, Gotthardt T, von Korn H, Lauer B
Editorial
94
The challenge of innovation: lost opportunities and new and uncharted futures
Serruys PW
EuroInterv.2008;3:533
95
Have we been misled by the ESC DES firestorm?
Cook S, Meier B
EuroInterv.2008;3:535-537
96
Residual shunting after treatment of a persistent arterial duct
Witsenburg M, Bogers A
EuroInterv.2008;3:539-540
97
Patient and staff radiation doses should be known by interventional cardiologists
Vano E
EuroInterv.2008;3:541-542
EAPCI column
98
EAPCI membership: converging worlds and techniques
Wijns W
EuroInterv.2008;3:543-545
Clinical research
99
Tryton I, First-In-Man (FIM) study: six month clinical and angiographic outcome, analysis with new quantitative coronary angiography dedicated for bifurcation lesions
Onuma Y, Müller R, Ramcharitar S, Geuns R-J, Louvard Y, Morel M-A, Morice M-C, Davis R, Kaplan A, Lefèvre T, Grube E, Serruys PW
EuroInterv.2008;3:546-552
100
A novel dedicated quantitative coronary analysis methodology for bifurcation lesions
Ramcharitar S, Onuma Y, Aben J-P, Consten C, Weijers B, Morel M-A, Serruys PW
EuroInterv.2008;3:553-557
101
First-in-human feasibility and safety study of a true bifurcated stent for the treatment of bifurcation coronary artery lesions (DBS stent): six month angiographic results and five year clinical follow-up
Dibie A, Chevalier B, Guyon P, Fajadet J, Lefèvre T, Slama M, Royer T, Glatt B, Philippe F, Laborde F, Larrazet F
EuroInterv.2008;3:558-565
102
Differentiated analysis of an everolimus-eluting stent and a paclitaxel-eluting stent among higher risk subgroups for restenosis: results from the SPIRIT II trial
Khattab A, Richardt G, Verin V, Kelbaek H, Macaya C, Berland J, Miquel-Hebert K, Dorange C, Serruys PW, on behalf of the SPIRIT II Investigators
EuroInterv.2008;3:566-573
103
First clinical comparison of Nobori-Biolimus A9 eluting stents with Cypher-Sirolimus eluting stents: NOBORI CORE nine months angiographic and one year clinical outcomes
Ostojic M, Sagic D, Beleslin B, Jung R, Perisic Z, Jagic N, Nedeljkovic M, Mangovski L, Milosavljevic B, Stojkovic S, Orlic D, Antonic Z, Miloradovic V, Topic D, Paunovic D, for the NOBORI CORE Investigators
EuroInterv.2008;3:574-579
104
Optical coherence tomography to assess malapposition in overlapping drug-eluting stents
Tanigawa J, Barlis P, Dimopoulos K, Di Mario C
EuroInterv.2008;3:580-583
105
Percutaneous closure of previously surgical treated arterial ducts
Kusa J, Szkutnik M, Czerpak B, Bialkowski J
EuroInterv.2008;3:584-587
106
Use of endovascular clamping as neuroprotection during carotid stenting in the presence of a critical ipsilateral stenosis of the external carotid artery This article contains pictures and/or videos
Stabile E, Sorropago G, Tesorio T, Salemme L, Ambrosini V, Cioppa A, Popusoi G, Nammas W, Biamino G, Rubino P
EuroInterv.2008;3:588-592
107
A multicentre survey of patient exposure to ionising radiation during interventional cardiology procedures in France
Bar O, Maccia C, Pagès P, Blanchard D
EuroInterv.2008;3:593-599
108
Haemodynamic effects, safety, and tolerability of haemoglobin-based oxygen carrier-201 in patients undergoing PCI for CAD
Serruys PW, Vranckx P, Slagboom T, Regar E, Meliga E, de Winter RJ, Heyndrickx G, Schuler G, van Remortel E, Dubé GP, Symons J, for the COR-0001 trial investigat
EuroInterv.2008;3:600-609
109
Ischaemic events and bleeding in patients undergoing percutaneous coronary intervention with concomitant bivalirudin treatment
Madsen JK, Chevalier B, Darius H, Rutsch W, Wójcik J, Schneider S, Allikmets K, on behalf of the ImproveR investigator group group
EuroInterv.2008;3:610-616
110
A novel penetration catheter (Tornus) as bail-out device after balloon failure to recanalise long, old calcified chronic occlusions
Reifart N, Enayat D, Giokoglu K
EuroInterv.2008;3:617-621
Expert review
111
Spelling out risk reduction strategies for intracoronary stenting
Lanzer P, Prechelt L
EuroInterv.2008;3:622-626
How should I treat?
112
Myocardial infarction in a patient with sickle cell trait. Treatment dilemmas and imaging findings at follow-up This article contains pictures and/or videos
van Mieghem C, Ramcharitar S, Barlis P, Oosterhuis W, Kik C, de Feyter P, Serruys PW
EuroInterv.2008;3:627-634
Technical report
113
The vPredict™ Optical Catheter System: Intravascular Raman Spectroscopy
Brennan JF, Nazemi J, Motz J, Ramcharitar S
EuroInterv.2008;3:635-638
114
ClearWay™ RX - Rapid exchange therapeutic perfusion catheter This article contains pictures and/or videos
Saraf S, Ong P, Gorog DA
EuroInterv.2008;3:639-642
Volume 3 Number 5 has been released thanks to the support of the following partners:
  • Abbott Vascular Devices
  • Biosensors
  • Cordis, a Johnson & Johnson company
  • Hexacath
  • Invatec
  • Medtronic
  • Terumo

Online ISSN 1969-6213 - Print ISSN 1774-024X